Safety and Efficiency Study of CD19-PD1-CART Cell in Relapsed/Refractory B Cell Lymphoma

Clinical trial NCT04163302 · UNKNOWN

Trial details

NCT number: NCT04163302
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, B-Cell

Start date: 2019-07-07
Primary completion: 2021-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.